Rothschild & Co Asset Management US’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-5,310
Closed -$552K 456
2017
Q2
$552K Sell
5,310
-981
-16% -$94.3K 0.01% 479
2017
Q1
$536K Sell
6,291
-2,862
-31% -$226K 0.01% 464
2016
Q4
$645K Buy
9,153
+1,530
+20% +$112K 0.01% 455
2016
Q3
$614K Buy
7,623
+81
+1% +$6.2K 0.01% 395
2016
Q2
$554K Buy
7,542
+864
+13% +$60.8K 0.01% 382
2016
Q1
$446K Buy
6,678
+1,854
+38% +$115K 0.01% 344
2015
Q4
$293K Buy
+4,824
New +$271K 0.01% 380

Other funds holding ISRG

Rothschild & Co Asset Management US's ISRG Position: Q3 2017 in Review

Rothschild & Co Asset Management US sold out of Intuitive Surgical (ISRG) in Q3 2017, closing a stake of 5,310 shares — an estimated $552K sold.

Rothschild & Co Asset Management US first reported a position in ISRG in Q4 2015 and held it in 7 quarters. The position peaked at $645K in Q4 2016. 648 funds tracked by Wall St. Rank hold ISRG as of Q3 2017.

  • Rothschild & Co Asset Management US reported no remaining Intuitive Surgical position as of Q3 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 5,310 Intuitive Surgical shares in Q3 2017, an estimated $552K.
  • Rothschild & Co Asset Management US first reported a position in Intuitive Surgical in Q4 2015 and held it in 7 quarters.
  • Rothschild & Co Asset Management US's Intuitive Surgical position peaked at $645K in Q4 2016.
  • 648 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2017, filed 8 Nov 2017.